Karel Bastl

Carebot is a state-of-the-art tool for computer-aided diagnosis. Within seconds, not only can Carebot determine the patients findings, but it can also mark them locally, saving the doctor valuable time, and eliminating the possibility of human error. Thanks to advanced artificial intelligence and computer vision algorithms, it can detect even the smallest nuances and findings in chest X-ray images with high accuracy and efficiency. The robustness of the model lends itself to use as a dedicated API for PACS systems, as well as a compact web application that is always at the physicians fingertips. Carebot saves lives, saves money for the health system, and improves the quality of healthcare.

The mission of CasInvent Pharma is to bring new therapeutic options for the treatment of selected leukemias to market. We are developing highly selective small molecule inhibitors of casein kinase I (CK1), and our main development program is focused on the identification of new drugs for the treatment of acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). CasInvent Pharma was established in 2020 as a spin-off company of Masaryk University in cooperation with the investment partner i&i Prague.

Carebot is a state-of-the-art tool for computer-aided diagnosis. Within seconds, not only can Carebot determine the patients findings, but it can also mark them locally, saving the doctor valuable time, and eliminating the possibility of human error. Thanks to advanced artificial intelligence and computer vision algorithms, it can detect even the smallest nuances and findings in chest X-ray images with high accuracy and efficiency. The robustness of the model lends itself to use as a dedicated API for PACS systems, as well as a compact web application that is always at the physicians fingertips. Carebot saves lives, saves money for the health system, and improves the quality of healthcare.